Enterprise Solutions

  1. Steriles Express: GMP Clinical Batch In 20 Weeks 10/8/2026

    A contractually committed 20-week path from development to a Phase 1 or 2 GMP clinical batch, with delivery risk shared through a pay-for-performance structure for sterile vial products.

  2. Closed System Cell Culture Flasks 10/8/2026

    Closed, aseptic flasks in three surface areas support controlled cell expansion in therapy workflows, with sterile connections that carry seed trains into larger multilayer vessels.

  3. Maintaining Consistency Across Batches, Scales, And Sites, Powered By ExellenS™ 10/6/2026

    Biological variability and process sensitivity make consistency across batches, scales, and sites hard to hold. A standardized operational framework aims to keep execution aligned and results predictable.

  4. Building The Infrastructure Behind Cell Therapy Manufacturing 10/2/2026

    A small automation shop focused on cell therapy manufacturing grew into a platform covering equipment, consumables, software, and industrialization services for commercial-scale production runs.

  5. RC-40™ Automated Roller Bottle System Solution 9/27/2026

    Scaling adherent cell culture? Learn how automation, closed processing, and roller bottle technology can improve consistency, reduce labor, and boost efficiency.

  6. Secure Scalable Supply Of Critical Assay Proteins For Diagnostic R&D 9/26/2026

    Our custom expression platform directly addresses the primary host limitations in early-to-mid stage assay development:

  7. Analytical Services Overview: Comprehensive GMP Analytical Services 9/24/2026

    GMP analytical services for cell banking, bioassays, environmental monitoring, and nucleic acid testing to support quality control and batch release.

  8. Unsurpassed Knowledge In Scale Up And Commercialization 9/24/2026

    Integrated plasmid DNA, cell and gene therapy manufacturing supported by scalable platforms, onsite testing, and global expertise from clinical development through commercialization.

  9. Mammalian Manufacturing Solutions: End-To-End Manufacturing Capabilities 9/24/2026

    Global mammalian manufacturing capabilities span cell banking, process development, analytical testing, and commercial production with scalable capacity and flexible technologies.

  10. Supporting Your Complex Drug Product Needs 9/24/2026

    Flexible fill-finish capabilities for clinical and commercial products, including packaging, testing, and release services across a global GMP network.